Endo International | ENDP - Stock


Endo International reported $274.5M in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Amarin USD 184.7M 13.46M Sep/2025
ANI Pharmaceuticals USD 143.07M 3.41M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pacira USD 152.86M 4.82M Dec/2025
Perrigo USD 1.15B 78M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Phibro Animal Health USD 517.35M 45.57M Dec/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Takeda JPY 1.41T 107.71B Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Xeris Pharmaceuticals USD 68.67M 1.21M Dec/2025
Zoetis USD 2.43B 35M Dec/2025